This article discusses a number of factors that may influence the behaviour of conjugated biopharmaceuticals. Optimizing bioconjugation processes may be critical to achieve the desired drug performance.
Alastair H Dent
Advertisement
Articles by Alastair H Dent
Advertisement
Latest Updated Articles
Optimizing bioconjugation processesPublished: May 1st 2007 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Standardizing Operations to Meet Global Sustainability and Resilience Goals
2
Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025
3
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
4
PharmTech Weekly News Roundup — Week of October 27, 2025
5
